Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-01 Sale |
2023-03-03 5:48 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
25,000 | $18.61 | $465,303 | 2,880,761 (Indirect) |
View |
| 2023-02-17 Sale |
2023-02-21 5:01 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
9,377 | $20.03 | $187,790 | 262,128 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 5:35 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
930 | $19.57 | $18,203 | 320,380 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 5:30 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
674 | $19.57 | $13,192 | 2,278,288 (Indirect Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 5:26 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
3,022 | $19.57 | $59,150 | 1,860,364 (Indirect Direct) |
View |
| 2023-02-10 Sale |
2023-02-13 6:28 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $20.07 | $200,659 | 2,241,710 (Indirect Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 4:48 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
25,000 | $21.23 | $530,794 | 2,905,761 (Indirect) |
View |
| 2023-01-23 Sale |
2023-01-24 5:11 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $22 | $274,988 | 1,744,634 (Indirect Direct) |
View |
| 2023-01-20 Sale |
2023-01-23 6:00 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $22.75 | $227,523 | 268,810 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 5:09 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $22.86 | $228,644 | 2,250,148 (Indirect Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:51 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
25,000 | $20.65 | $516,147 | 2,930,761 (Indirect) |
View |
| 2022-12-21 Sale |
2022-12-22 5:50 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20.32 | $253,969 | 1,755,572 (Indirect Direct) |
View |
| 2022-12-20 Sale |
2022-12-22 5:43 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $20.07 | $200,650 | 276,497 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-12 4:56 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
4,358 | $22.08 | $96,210 | 2,955,761 (Indirect) |
View |
| 2022-12-01 Sale |
2022-12-05 4:57 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
10,000 | $21.65 | $216,480 | 2,960,119 (Indirect) |
View |
| 2022-12-01 Sale |
2022-12-05 4:43 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $21.45 | $214,530 | 2,260,148 (Indirect Direct) |
View |
| 2022-11-21 Sale |
2022-11-22 6:46 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $20.76 | $207,570 | 286,497 (Direct) |
View |
| 2022-11-21 Sale |
2022-11-22 6:43 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20.76 | $259,479 | 1,768,072 (Indirect Direct) |
View |
| 2022-11-16 Sale |
2022-11-17 5:49 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
430 | $21.46 | $9,228 | 312,997 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-17 5:41 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
377 | $21.46 | $8,090 | 2,284,400 (Indirect Direct) |
View |
| 2022-11-16 Sale |
2022-11-17 5:33 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
1,513 | $21.46 | $32,469 | 1,823,324 (Indirect Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 5:49 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $20.03 | $200,313 | 294,401 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 5:44 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
10,000 | $20.03 | $200,278 | 2,970,119 (Indirect) |
View |
| 2022-11-01 Sale |
2022-11-03 5:36 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $20 | $200,050 | 2,269,338 (Indirect Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 5:30 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20.03 | $250,355 | 1,778,523 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:36 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $20.05 | $200,473 | 304,401 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:32 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
10,000 | $20.03 | $200,315 | 7,394,527 (Indirect) |
View |
| 2022-10-03 Sale |
2022-10-05 4:25 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $19.99 | $199,852 | 2,279,338 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:22 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20.05 | $250,646 | 1,791,023 (Indirect Direct) |
View |
| 2022-09-21 Sale |
2022-09-22 4:00 pm |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
613,603 | $18.55 | $11,380,779 | 8,464,301 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-22 4:00 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
613,603 | $18.55 | $11,380,779 | 8,904,527 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 6:05 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
340,702 | $20.44 | $6,963,116 | 9,517,624 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 5:47 pm |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
340,702 | $20.44 | $6,963,116 | 9,077,904 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:53 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
245,039 | $23.76 | $5,823,084 | 9,858,326 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-15 Exercise |
2023-02-17 5:35 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
3,625 | $0 | 320,380 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 5:30 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
2,624 | $0 | 2,278,288 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 5:26 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
8,312 | $0 | 1,860,364 (Direct) |
View |
| 2022-03-31 Ownership |
2023-02-13 6:20 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
281,574 | $0 | 1,473,998 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 5:02 pm |
N/A 2033-01-16 |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
152,000 | $0 | 152,000 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:59 pm |
N/A 2033-01-16 |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:52 pm |
N/A 2033-01-16 |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
320,000 | $0 | 320,000 (Direct) |
View |
| 2022-12-12 Other |
2022-12-14 4:54 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. 10% Owner |
600,854 | $0 | 6,609,388 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 5:49 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
1,375 | $0 | 312,997 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 5:41 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
1,187 | $0 | 2,284,400 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 5:33 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
3,562 | $0 | 1,823,324 (Direct) |
View |
| 2022-09-21 Other |
2022-09-22 4:00 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
1,500,000 | $0 | 8,464,301 (Direct) |
View |
| 2022-09-21 Other |
2022-09-22 4:00 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
1,500,000 | $0 | 8,904,527 (Indirect) |
View |
| 2022-09-19 Other |
2022-09-21 4:58 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. 10% Owner |
600,854 | $0 | 7,210,242 (Direct) |
View |